ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE: 600479)
Health Care · Pharmaceuticals · CN
CN¥9.76
-2.40% today · -13.7% 1Y
ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE: 600479) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $714.62M and employs 5,041 people.
Over the last twelve months the share price has lost 13.7%, trading between 9.20 and 11.53.
Tweenvest scores ZhuZhou QianJin Pharmaceutical Co.,Ltd across four factors: quality 82/100, value 39/100, growth 36/100, dividend 88/100. Its strongest factor is dividend.
600479 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $714.62M
- Revenue (TTM)
- $521.08M
- P/E
- 14.18
- EPS
- 0.69
- Dividend yield
- 3.89%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥11.53
- 52-week low
- CN¥9.20
- Avg volume (3M)
- —
- Shares outstanding
- 492.21M
- Employees
- 5,041
- Next earnings
- —
About ZhuZhou QianJin Pharmaceutical Co.,Ltd
Established in 1993 and headquartered in Zhuzhou, China, ZhuZhou QianJin Pharmaceutical Co.,Ltd operates as a leading manufacturer and distributor of pharmaceutical goods throughout China. The company boasts a comprehensive product portfolio, encompassing treatments for women's health, pediatric ailments, dermatological concerns, anti-infectives, and conditions affecting the circulatory, endocrine, digestive, nervous, and cardiovascular systems. Additionally, they offer specialized medications and traditional Chinese remedies. These diverse pharmaceutical offerings are presented in various formats, including pills, tablets, capsules, granules, powders, decoctions, and liquid solutions. Beyond its core pharmaceutical business, ZhuZhou QianJin also produces ginger-based beverages, feminine hygiene products, and alcoholic beverages.
- ISIN
- CNE000001GX3
- Founded
- 1966
- Listed since
- Mar 12, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.85 | -3.47% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.06 | -0.76% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.94 | -1.60% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.25 | -1.14% |
Figures last refreshed Aug 18, 2026.